LENZ Therapeutics (LENZ) Amortizatization of Intangibles (2022 - 2026)
LENZ Therapeutics' (LENZ) quarterly Amortizatization of Intangibles came in at $316000.0 in Q1 2026, down 72.13% year-on-year from $1.1 million in Q1 2025, and down 48.03% on a QoQ basis from $608000.0 in Q4 2025.
LENZ Therapeutics (LENZ) Amortizatization of Intangibles (2022 - 2026) Analysis & Trends
LENZ Therapeutics (LENZ) has 5 years of Amortizatization of Intangibles data on file, last reported at $316000.0 in Q1 2026.
- On a quarterly basis, Amortizatization of Intangibles fell 72.13% year-over-year to $316000.0 in Q1 2026; TTM through Mar 2026 was $2.6 million, a 46.86% decrease from a year earlier, with the FY2025 full-year figure at $3.4 million, down 15.14% from the prior year.
- Amortizatization of Intangibles for Q1 2026 stood at $316000.0, down from $608000.0 in the prior quarter.
- Over the last five years, Amortizatization of Intangibles for LENZ reached as high as $1.4 million in Q4 2024 and fell as low as -$45000.0 in Q1 2022.
- Historically, Amortizatization of Intangibles has averaged $649937.5 across 5 years, with a median of $585000.0 in 2022.
- Across the five-year window, Amortizatization of Intangibles soared 4947.37% in 2024 and plunged 72.13% in 2026, its largest moves.
- Year by year, Amortizatization of Intangibles stood at $1.1 million in 2022, then plunged by 54.42% to $511000.0 in 2023, then jumped by 178.67% to $1.4 million in 2024, then plunged by 57.3% to $608000.0 in 2025, then slumped by 48.03% to $316000.0 in 2026.
- Per Business Quant data, the three most recent Amortizatization of Intangibles figures were $316000.0 in Q1 2026, $608000.0 in Q4 2025, and $779000.0 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | - |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | 3.22 Mn |
| 10 | LENZ Therapeutics | 177.61 Mn | -80.77 Mn | 825,000.00 | 316,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 316,000.00 |
| Mar 31, 2026 | 316,000.00 |
| Dec 31, 2025 | 608,000.00 |
| Dec 31, 2025 | 608,000.00 |
| Sep 30, 2025 | 779,000.00 |
| Sep 30, 2025 | 779,000.00 |
| Jun 30, 2025 | 888,000.00 |
| Jun 30, 2025 | 888,000.00 |
| Mar 31, 2025 | 1.13 Mn |
| Mar 31, 2025 | 1.13 Mn |
| Dec 31, 2024 | 1.42 Mn |
| Dec 31, 2024 | 1.42 Mn |
| Sep 30, 2024 | 1.36 Mn |
| Sep 30, 2024 | 1.36 Mn |
| Jun 30, 2024 | 959,000.00 |
| Jun 30, 2024 | 959,000.00 |
| Mar 31, 2024 | 275,000.00 |
| Mar 31, 2024 | 275,000.00 |
| Dec 31, 2023 | 511,000.00 |
| Dec 31, 2023 | 511,000.00 |